MediciNova
MNOV
$1.31
Share price
-0.76%
Change (1 day)
-38.79%
Change (1 year)
Categories
Operating Margin for MediciNova (MNOV)
Operating Margin as of April 2024 (TTM): -250.93%
According to MediciNova's latest financial reports and stock price the company's current Operating Margin is -250.93%. At the end of 2021 the company had an Operating Margin of -250.94%.
Operating Margin history for MediciNova from 2004 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -250.94% | |
| 2013 | -67.04% | -95.09% |
| 2012 | -1,364.37% | |
| 2006 | -15,794.30% | 322.09% |
| 2005 | -3,741.93% | -62.26% |
| 2004 | -9,915.19% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -106.88% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 24.66% | -109.83% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -107.26% | 🇫🇷 France |
 Titan Pharmaceuticals
TTNP | -2,570.78% | 924.50% | 🇺🇸 USA |
 Alkermes ALKS | -15.04% | -94.01% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | -20.53% | -91.82% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.